Literature DB >> 797495

Drug dosage in renal disease.

L Dettli.   

Abstract

Based on the well known linear relationship between the overall drug elimination rate constant and the endogenous creatinine clearance, it is shown how individual drug elimination parameters in patients with renal disease can be estimated from the patient's creatinine clearance or serum creatinine concentration. By means of a simple nomogram the elimination rate fraction is determined which describes the elimination rate of the drug as a fraction of its normal elimination rate constant. Based on the estimated elimination rate fraction the dosage regimen in the patient with renal disease is individually modified according to pharmacokinetic principles. At present the described method can be used with 45 different drugs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 797495     DOI: 10.2165/00003088-197601020-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  22 in total

1.  Calculation of drug dosage regimens in patients with renal disease: a new nomographic method.

Authors:  P Spring
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-01

2.  Pharmacokinetics and dosing of antimicrobial agents in renal impairment. I.

Authors:  E A Jackson; D C McLeod
Journal:  Am J Hosp Pharm       Date:  1974-01

3.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

4.  Individualization of drug dosage in patients with renal disease.

Authors:  L Dettli
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

5.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

6.  Relevant pharmacokinetics of antimicrobial drugs.

Authors:  J G Wagner
Journal:  Med Clin North Am       Date:  1974-05       Impact factor: 5.456

7.  Drug elimination and apparent volume of distribution in multicompartment systems.

Authors:  M Gibaldi; D Perrier
Journal:  J Pharm Sci       Date:  1972-06       Impact factor: 3.534

8.  Antimicrobial therapy in patients with renal insufficiency.

Authors:  R J Bulger; R G Petersdorf
Journal:  Postgrad Med       Date:  1970-01       Impact factor: 3.840

9.  A practical guide to drug usage in adult patients with impaired renal function.

Authors:  W M Bennett; I Singer; C H Coggins
Journal:  JAMA       Date:  1970-11-23       Impact factor: 56.272

10.  Correlation of serum creatinine concentration and kanamycin half-life. Therapeutic implications.

Authors:  R E Cutler; B M Orme
Journal:  JAMA       Date:  1969-07-28       Impact factor: 56.272

View more
  55 in total

1.  Understanding usage patterns of handheld computers in clinical practice.

Authors:  Mathias Tschopp; Christian Lovis; Antoine Geissbuhler
Journal:  Proc AMIA Symp       Date:  2002

Review 2.  Drug therapy in patients with chronic renal failure.

Authors:  Bertram Hartmann; David Czock; Frieder Keller
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

Review 3.  Diseases and drug protein binding.

Authors:  J P Tillement; F Lhoste; J F Giudicelli
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

Review 4.  [Antibiotic dosing for renal function disorders and continuous renal replacement therapy].

Authors:  Erik Michael; Detlef Kindgen-Milles
Journal:  Anaesthesist       Date:  2015-04       Impact factor: 1.041

5.  Suboptimal antimicrobial drug exposure in patients with renal impairment.

Authors:  David Czock; Martino Spitaletta; Frieder Keller
Journal:  Int J Clin Pharm       Date:  2015-05-28

6.  Poor correlation between single-dose data and steady-state kinetics for phenobarbitone, primidone, carbamazepine and sodium valproate in children during monotherapy. Possible reasons for the lack of correlation.

Authors:  J A Armijo; J L Herranz; R Arteaga; R Valiente
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

7.  Antipyrine metabolite formation and excretion in patients with chronic renal failure.

Authors:  M W Teunissen; D Kampf; I Roots; N P Vermeulen; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 8.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

9.  Dosage adjustment for ceftazidime in patients with impaired renal function.

Authors:  R van Dalen; T B Vree; A M Baars; E Termond
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Pharmacokinetics in patients with cardiac failure.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.